Contents
- Why melanoma matters: An update of the epidemiology and impact of melanoma
- Staging and the role of sentinel node biopsy, imaging and molecular biomarkers in the clinic
- Optimizing adjuvant immunotherapy: Perspectives on the latest data
- Management of metastatic disease: Today’s therapeutics and tomorrow’s options
- Conclusions